Assertio Holdings Inc (ASRT)
1.025
+0.02
(+1.49%)
USD |
NASDAQ |
May 03, 16:00
1.025
0.00 (0.00%)
After-Hours: 19:04
Assertio Holdings Price to Book Value: 0.7055 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 02, 2024 | 0.6952 |
May 01, 2024 | 0.6341 |
April 30, 2024 | 0.6093 |
April 29, 2024 | 0.5837 |
April 26, 2024 | 0.5701 |
April 25, 2024 | 0.5404 |
April 24, 2024 | 0.5958 |
April 23, 2024 | 0.6261 |
April 22, 2024 | 0.5956 |
April 19, 2024 | 0.5321 |
April 18, 2024 | 0.519 |
April 17, 2024 | 0.5369 |
April 16, 2024 | 0.5477 |
April 15, 2024 | 0.5606 |
April 12, 2024 | 0.5976 |
April 11, 2024 | 0.6073 |
April 10, 2024 | 0.6179 |
April 09, 2024 | 0.6245 |
April 08, 2024 | 0.6352 |
April 05, 2024 | 0.6524 |
April 04, 2024 | 0.6355 |
April 03, 2024 | 0.6363 |
April 02, 2024 | 0.6398 |
April 01, 2024 | 0.6442 |
March 28, 2024 | 0.6603 |
Date | Value |
---|---|
March 27, 2024 | 0.6815 |
March 26, 2024 | 0.7021 |
March 25, 2024 | 0.7159 |
March 22, 2024 | 0.7159 |
March 21, 2024 | 0.7228 |
March 20, 2024 | 0.7159 |
March 19, 2024 | 0.6952 |
March 18, 2024 | 0.7159 |
March 15, 2024 | 0.771 |
March 14, 2024 | 0.7503 |
March 13, 2024 | 0.7847 |
March 12, 2024 | 0.6952 |
March 11, 2024 | 0.6434 |
March 08, 2024 | 0.6276 |
March 07, 2024 | 0.6276 |
March 06, 2024 | 0.6126 |
March 05, 2024 | 0.6108 |
March 04, 2024 | 0.6054 |
March 01, 2024 | 0.6054 |
February 29, 2024 | 0.6063 |
February 28, 2024 | 0.5812 |
February 27, 2024 | 0.574 |
February 26, 2024 | 0.5646 |
February 23, 2024 | 0.5625 |
February 22, 2024 | 0.5522 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2285
Minimum
Dec 05 2019
3.755
Maximum
Feb 16 2021
0.9931
Average
0.9682
Median
Price to Book Value Benchmarks
Ocular Therapeutix Inc | 10.05 |
Cormedix Inc | 4.574 |
Verastem Inc | 4.808 |
Puma Biotechnology Inc | 4.397 |
CytomX Therapeutics Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 0.5018 |
Price to Free Cash Flow | 1.558 |
Price | 1.025 |
Earnings Yield | -359.0% |
Market Cap | 97.37M |
Operating PE Ratio | 4.757 |